Funder
Western Norway Familial Cancer Center, Haukeland University Hospital, Norway and Centre of Clinical Research, Haukelan University Hospital, Norway
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Oncology
Reference51 articles.
1. Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105:812–22.
2. Brohet RM, Velthuizen ME, Hogervorst FB, Meijers-Heijboer HE, Seynaeve C, Collee MJ, et al. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet. 2014;51:98–107.
3. Hartmann LC, Lindor NM. The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer. N Engl J Med. 2016;374:454–68.
4. Norwegian breast cancer group, (NBCG). Norwegian guidelines for diagnosis, treatment and follow up of patients with breast cancer 2016. Available at: http://nbcg.no/retningslinjer/ . Accessed 5 Jan 2017.
5. Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001;93:1633–7.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献